CALLA: Durvalumab versus Placebo with Chemoradiotherapy for Locally Advanced Cervical Cancer Last updated on Jun 8, 2026 Previous SCORPION: Primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer Next KEYNOTE A18: Pembrolizumab Plus Chemoradiotherapy for High-Risk Locally Advanced Cervical Cancer
